Clinical Trials

Leading the treatment of infectious conjunctivitis

The RUBY Trial evaluated the anti-viral safety and efficacy of OKG-0301.

Results demonstrated that OKG-0301 is safe, well-tolerated and accelerates viral clearance in a dose-responsive fashion.

OKG-0301 is a safe and effective antiviral

More information about clinical trial results can be found at